OPEN END TURBO PUT WARRANT - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 11:00:13 31/05/2024 pm IST | ||
| 27.26 EUR | +0.93% |
|
| Current month | -12.74% | ||
| 1 month | -12.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 27.26 | +0.93% |
| 30/24/30 | 27.01 | -3.43% |
| 29/24/29 | 27.97 | -0.53% |
| 28/24/28 | 28.12 | +2.63% |
| 27/24/27 | 27.4 | -1.51% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 11:00 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | UBS |
| WKN | UM1U48 |
| ISIN | DE000UM1U486 |
| Date issued | 12/02/2024 |
| Strike | 1,109 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 34.9 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 36.45 € |
|---|---|
| Lowest since issue | 26.37 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
820.3
USD
Average target price
852.5
USD
Spread / Average Target
+3.92%
- Stock Market
- Certificates
- Certificat
